From Colonial Research Spirit to Global Commitment: Bayer and African Sleeping Sickness in the Mirror of History
- PMID: 32164154
- PMCID: PMC7157646
- DOI: 10.3390/tropicalmed5010042
From Colonial Research Spirit to Global Commitment: Bayer and African Sleeping Sickness in the Mirror of History
Abstract
In the early 20th century, a series of epidemics across equatorial Africa brought African sleeping sickness (human African trypanosomiasis, HAT) to the attention of the European colonial administrations. This disease presented an exciting challenge for microbiologists across Europe to study the disease, discover the pathogen and search for an effective treatment. In 1923, the first "remedy for tropical diseases"-Suramin-manufactured by Bayer AG came onto the market under the brand name "Germanin." The development and life cycle of this product-which today is still the medicine of choice for Trypanosoma brucei (T.b), hodesiense infections-reflect medical progress as well as the successes and failures in fighting the disease in the context of historic political changes over the last 100 years.
Keywords: African sleeping sickness; development of treatment; medical history; political history; suramin.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
[The sleeping disease drug Germanine as an instrument for propaganda: reception in literature and film during National Socialism].Wurzbg Medizinhist Mitt. 2010;29:43-72. Wurzbg Medizinhist Mitt. 2010. PMID: 21563369 German.
-
History of sleeping sickness (African trypanosomiasis).Infect Dis Clin North Am. 2004 Jun;18(2):231-45. doi: 10.1016/j.idc.2004.01.004. Infect Dis Clin North Am. 2004. PMID: 15145378
-
Current situation of African trypanosomiasis.Acta Trop. 1993 Sep;54(3-4):153-62. doi: 10.1016/0001-706x(93)90089-t. Acta Trop. 1993. PMID: 7902654 Review.
-
African trypanosomiasis.Ann Trop Med Parasitol. 2006 Dec;100(8):679-701. doi: 10.1179/136485906X112211. Ann Trop Med Parasitol. 2006. PMID: 17227648 Review.
-
Evaluating the impact of targeting livestock for the prevention of human and animal trypanosomiasis, at village level, in districts newly affected with T. b. rhodesiense in Uganda.Infect Dis Poverty. 2017 Feb 6;6(1):16. doi: 10.1186/s40249-016-0224-8. Infect Dis Poverty. 2017. PMID: 28162093 Free PMC article.
Cited by
-
Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder.Ann Gen Psychiatry. 2023 Nov 6;22(1):45. doi: 10.1186/s12991-023-00477-8. Ann Gen Psychiatry. 2023. PMID: 37932739 Free PMC article.
-
100 years since the publication of the suramin formula.Parasitol Res. 2023 Dec 7;123(1):11. doi: 10.1007/s00436-023-08027-7. Parasitol Res. 2023. PMID: 38057659 Free PMC article. Review.
-
Transforming the chemotherapy of human African trypanosomiasis.Clin Microbiol Rev. 2025 Mar 13;38(1):e0015323. doi: 10.1128/cmr.00153-23. Epub 2025 Jan 8. Clin Microbiol Rev. 2025. PMID: 39772631 Review.
-
Antileishmanial and Antitrypanosomes Drugs for the Current Century.Microorganisms. 2023 Dec 26;12(1):43. doi: 10.3390/microorganisms12010043. Microorganisms. 2023. PMID: 38257870 Free PMC article.
References
-
- Neill D.J. Networks in Tropical Medicine: Internationalism, Colonialism, and the Rise of a Medical Specialty, 1890–1930. Stanford University Press; Stanford, CA, USA: 2012. pp. 104, 105, 111–133, 158–175.
-
- Tilley H. Africa as a Living Laboratory. University of Chicago Press; Chicago, IL, USA: 2011. pp. 176–191.
LinkOut - more resources
Full Text Sources